Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Geron Corp GERN

Alternate Symbol(s):  GERNW

Healthcare Biotechnology
Geron Corporation is a late-stage clinical biopharmaceutical company developing investigational first-in-class telomerase inhibitor, imetelstat, to treat hematologic malignancies. The Company is engaged in the development of therapeutic products for oncology. Its lead indication for imetelstat is in Low or Intermediate-1 risk myelodysplastic syndromes. It is developing imetelstat for the... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:GERN)

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire 3 days ago

Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development

Business Wire 13 days ago

Geron to Participate in the Stifel 2024 Healthcare Conference

Business Wire 13 days ago

Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million

GlobeNewswire November 7, 2024

Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors

Business Wire November 7, 2024

Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Business Wire November 7, 2024

Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO(TM) (imetelstat) in Myeloid Hematologic Malignancies

Business Wire November 5, 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire October 17, 2024

Geron to Announce Third Quarter 2024 Financial Results on November 7, 2024

Business Wire October 15, 2024
View More News ››

Opinion & Analysis (NDAQ:GERN)

Drug pricing, presidential politics, and three biotechs with promise

The Life Sciences Report April 13, 2016

Stock picks including a coal play

J.W. Cotton November 4, 2009

Profiting from the 'picks and shovels' of stem cell research

Andrew Mickey January 27, 2009

Make money from the next emerging boom

Andrew Mickey November 25, 2008

Cash-rich companies for the bear-market bounce

Jason Schwarz November 7, 2008
View More Opinion ››

Bullboard Posts (NDAQ:GERN)

Trader's notes

We’ve closed the gap—an excellent correction after the pump. The day before yesterday, there was a signal—a hammer—likely indicating a...
ChartEagle705 - 3 days ago

Short Short Short

The chart shows a clear downtrend, and I can see that the price has already made a new low and is now in a...
ChartEagle705 - 3 days ago

Geron Corporation Announces Appointment of Joseph Eid, M.D.

News; $GERN Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and DevelopmentGeron...
whytestocks - 13 days ago

Glta

Should we a climb today.
Tulsa123 - July 29, 2024

Wall Street

Absolutely think that this company has done an amazing job and the $ will go up.I hope they are correct. Glta
Tulsa123 - July 26, 2024

The news today?

Do we see a huge gain of attention and price rise coming soon? Fabulous investment info. Good Day 
Tulsa123 - July 26, 2024
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria, an interest in ...
View More »